145 related articles for article (PubMed ID: 37549827)
1. Attenuation of epithelial-mesenchymal transition via SGLT2 inhibition and diabetic cataract suppression by dapagliflozin nanoparticles treatment.
Chen YY; Chen CK; Wu TT; Ho CY; Yeh TC; Sun GC; Tseng CJ; Cheng PW
Life Sci; 2023 Oct; 330():122005. PubMed ID: 37549827
[TBL] [Abstract][Full Text] [Related]
2. Dapagliflozin Prevents NOX- and SGLT2-Dependent Oxidative Stress in Lens Cells Exposed to Fructose-Induced Diabetes Mellitus.
Chen YY; Wu TT; Ho CY; Yeh TC; Sun GC; Kung YH; Wong TY; Tseng CJ; Cheng PW
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491943
[TBL] [Abstract][Full Text] [Related]
3. AKR1B1-Induced Epithelial-Mesenchymal Transition Mediated by RAGE-Oxidative Stress in Diabetic Cataract Lens.
Wu TT; Chen YY; Chang HY; Kung YH; Tseng CJ; Cheng PW
Antioxidants (Basel); 2020 Mar; 9(4):. PubMed ID: 32218152
[TBL] [Abstract][Full Text] [Related]
4. Quercetin inhibited epithelial mesenchymal transition in diabetic rats, high-glucose-cultured lens, and SRA01/04 cells through transforming growth factor-β2/phosphoinositide 3-kinase/Akt pathway.
Du L; Hao M; Li C; Wu W; Wang W; Ma Z; Yang T; Zhang N; Isaac AT; Zhu X; Sun Y; Lu Q; Yin X
Mol Cell Endocrinol; 2017 Sep; 452():44-56. PubMed ID: 28501572
[TBL] [Abstract][Full Text] [Related]
5. Blocking of SGLT2 to Eliminate NADPH-Induced Oxidative Stress in Lenses of Animals with Fructose-Induced Diabetes Mellitus.
Chen YY; Wu TT; Ho CY; Yeh TC; Sun GC; Tseng CJ; Cheng PW
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806147
[TBL] [Abstract][Full Text] [Related]
6. 3H-1,2-Dithiole-3-Thione Protects Lens Epithelial Cells against Fructose-Induced Epithelial-Mesenchymal Transition via Activation of AMPK to Eliminate AKR1B1-Induced Oxidative Stress in Diabetes Mellitus.
Wu TT; Chen YY; Ho CY; Yeh TC; Sun GC; Tseng CJ; Cheng PW
Antioxidants (Basel); 2021 Jul; 10(7):. PubMed ID: 34356319
[TBL] [Abstract][Full Text] [Related]
7. The interaction between autophagy and the epithelial-mesenchymal transition mediated by NICD/ULK1 is involved in the formation of diabetic cataracts.
Ma J; Ye W; Yang Y; Wu T; Wang Y; Li J; Pei R; He M; Zhang L; Zhou J
Mol Med; 2022 Sep; 28(1):116. PubMed ID: 36104669
[TBL] [Abstract][Full Text] [Related]
8. Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.
Birnbaum Y; Bajaj M; Yang HC; Ye Y
Cardiovasc Drugs Ther; 2018 Apr; 32(2):135-145. PubMed ID: 29508169
[TBL] [Abstract][Full Text] [Related]
9. Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats.
Tian J; Zhang M; Suo M; Liu D; Wang X; Liu M; Pan J; Jin T; An F
J Cell Mol Med; 2021 Aug; 25(16):7642-7659. PubMed ID: 34169635
[TBL] [Abstract][Full Text] [Related]
10. Effects of the SGLT2 Inhibition on Cardiac Remodeling in Streptozotocin-Induced Diabetic Rats, a Model of Type 1 Diabetes Mellitus.
Rosa CM; Campos DHS; Reyes DRA; Damatto FC; Kurosaki LY; Pagan LU; Gomes MJ; Corrêa CR; Fernandes AAH; Okoshi MP; Okoshi K
Antioxidants (Basel); 2022 May; 11(5):. PubMed ID: 35624845
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of advanced glycation end-products in diabetic and inherited canine cataracts.
Bras ID; Colitz CM; Kusewitt DF; Chandler H; Lu P; Gemensky-Metzler AJ; Wilkie DA
Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):249-57. PubMed ID: 16896921
[TBL] [Abstract][Full Text] [Related]
12. Determining the Role of SGLT2 Inhibition with Dapagliflozin in the Development of Diabetic Retinopathy.
Herat LY; Matthews JR; Ong WE; Rakoczy EP; Schlaich MP; Matthews VB
Front Biosci (Landmark Ed); 2022 Dec; 27(12):321. PubMed ID: 36624945
[TBL] [Abstract][Full Text] [Related]
13. SGLT2 inhibition effect on salt-induced hypertension, RAAS, and Na
Kravtsova O; Bohovyk R; Levchenko V; Palygin O; Klemens CA; Rieg T; Staruschenko A
Am J Physiol Renal Physiol; 2022 Jun; 322(6):F692-F707. PubMed ID: 35466690
[TBL] [Abstract][Full Text] [Related]
14. Bone Morphogenetic Protein-7 Suppresses TGFβ2-Induced Epithelial-Mesenchymal Transition in the Lens: Implications for Cataract Prevention.
Shu DY; Wojciechowski MC; Lovicu FJ
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):781-796. PubMed ID: 28152139
[TBL] [Abstract][Full Text] [Related]
15. Effect of a combination of carnosine and aspirin eye drops on streptozotocin -- induced diabetic cataract in rats.
Shi Q; Yan H; Li MY; Harding JJ
Mol Vis; 2009 Oct; 15():2129-38. PubMed ID: 19898641
[TBL] [Abstract][Full Text] [Related]
16. LncRNA
Ye W; Ma J; Wang F; Wu T; He M; Li J; Pei R; Zhang L; Wang Y; Zhou J
Oxid Med Cell Longev; 2020; 2020():8184314. PubMed ID: 33274006
[TBL] [Abstract][Full Text] [Related]
17. Topical nerve growth factor attenuates streptozotocin-induced diabetic cataracts via polyol pathway inhibition and Na
Kim JY; Park JH; Kang SS; Hwang SB; Tchah H
Exp Eye Res; 2021 Jan; 202():108319. PubMed ID: 33080303
[TBL] [Abstract][Full Text] [Related]
18. Pre-hyperglycemia immune cell trafficking underlies subclinical diabetic cataractogenesis.
Ranaei Pirmardan E; Zhang Y; Barakat A; Naseri M; Russmann C; Hafezi-Moghadam A
J Biomed Sci; 2023 Jan; 30(1):6. PubMed ID: 36694206
[TBL] [Abstract][Full Text] [Related]
19. Matrix-bound AGEs enhance TGFβ2-mediated mesenchymal transition of lens epithelial cells via the noncanonical pathway: implications for secondary cataract formation.
Nam MH; Nagaraj RH
Biochem J; 2018 Apr; 475(8):1427-1440. PubMed ID: 29588342
[TBL] [Abstract][Full Text] [Related]
20. Effects of N-acetylcysteine and glutathione ethyl ester drops on streptozotocin-induced diabetic cataract in rats.
Zhang S; Chai FY; Yan H; Guo Y; Harding JJ
Mol Vis; 2008 May; 14():862-70. PubMed ID: 18490958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
